Skip Navigation
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
Chromosomes
  • Tools
  • Genetic and Physical SNP Maps
  • SNP500Cancer

Association List

[Full Text]
Displaying Investigations 1 to 61 of 61 found
From 16 References


Berger et al 2010, Genome Res
  Malignant melanoma Skin
ANKHD1/CYSTM1
t(5;5)(q31;q31)

Edgren et al 2011, Genome Biol
  Adenocarcinoma Breast
ANKHD1/PCDH1
t(5;5)(q31;q31)

Hu et al 2018, Nucleic Acids Res
  Adenocarcinoma Stomach
ANKHD1/PAIP2
t(5;5)(q31;q31)
  Malignant epithelial tumor, special type Uterus, corpus
ANKHD1-EIF4EBP3/CYSTM1
t(5;5)(q31;q31)
  Adenocarcinoma Lung
CDC23/CDC25C
t(5;5)(q31;q31)
  Malignant melanoma Skin
CDKL3/SIL1
t(5;5)(q31;q31)
  Adenocarcinoma Stomach
CTNNA1/REEP2
t(5;5)(q31;q31)
  Adenocarcinoma Oesophagus
CTNNA1/EGR1
t(5;5)(q31;q31)
  Adenocarcinoma Uterus, corpus
CTNNA1/WNT8A
t(5;5)(q31;q31)
  Mesenchymal tumor, NOS Unknown site
CTNNA1/CYSTM1
t(5;5)(q31;q31)
  Adenocarcinoma Uterus, corpus
DDX46/CDC25C
t(5;5)(q31;q31)
  Adenocarcinoma Uterus, corpus
DDX46/SEC24A
t(5;5)(q31;q31)
  Adenocarcinoma Pancreas
ETF1/HSPA9
t(5;5)(q31;q31)
  Transitional cell carcinoma Bladder
FNIP1/IL5
t(5;5)(q31;q31)
  Transitional cell carcinoma Bladder
FSTL4/SLC22A4
t(5;5)(q31;q31)
  Squamous cell carcinoma Lung
HARS/TMCO6
t(5;5)(q31;q31)
  Mesenchymal tumor, NOS Unknown site
PAIP2/SIL1
t(5;5)(q31;q31)
  Adenocarcinoma Uterus, corpus
RAD50/SLC22A4
t(5;5)(q31;q31)
  Adenocarcinoma Liver
RAD50/C5orf56
t(5;5)(q31;q31)
  Adenocarcinoma Liver
SEC24A/JADE2
t(5;5)(q31;q31)
  Adenocarcinoma Uterus, corpus
SIL1/DNAJC18
t(5;5)(q31;q31)
  Adenocarcinoma Uterus, corpus
SIL1/CTNNA1
t(5;5)(q31;q31)
  Mesenchymal tumor, NOS Unknown site
SIL1/PAIP2
t(5;5)(q31;q31)
  Adenocarcinoma Uterus, corpus
SIL1/SLC23A1
t(5;5)(q31;q31)
  Adenocarcinoma Kidney
SLC22A4/PDLIM4
t(5;5)(q31;q31)
  Adenocarcinoma Prostate
SPOCK1/CDC23
t(5;5)(q31;q31)
  Adenocarcinoma Liver
TMCO6/CYSTM1
t(5;5)(q31;q31)
  Adenocarcinoma Liver
UBE2D2/CTNNA1
t(5;5)(q31;q31)
  Squamous cell carcinoma Lung
UBE2D2/ARHGAP26
t(5;5)(q31;q31)
  Adenocarcinoma Liver
WDR55/PAIP2
t(5;5)(q31;q31)

Imielinski et al 2012, Cell
  Adenocarcinoma Lung
UBE2D2/MATR3
t(5;5)(q31;q31)

Iwakawa et al 2013, Genes Chromosomes Cancer
  Undifferentiated carcinoma, small cell Lung
JADE2/UBE2B
t(5;5)(q31;q31)

Lai et al 2015, BMC Genomics
  Adenocarcinoma Prostate
HARS2/ZMAT2
t(5;5)(q31;q31)

Liu et al 2016, EBioMedicine
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
YIPF5/NR3C1
t(5;5)(q31;q31)
B-Lineage
  Acute lymphoblastic leukemia/lymphoblastic lymphoma
SKP1/AFF4
t(5;5)(q31;q31)
B-Lineage

Maher et al 2009, Nature
  Adenocarcinoma Prostate
WDR55/DND1
t(5;5)(q31;q31)

Micci et al 2016, Genes Chromosomes Cancer
  Endometrial stromal sarcoma Uterus, corpus
H2AFY/HMHB1
t(5;5)(q31;q31)

Nome et al 2013, Transl Oncol
  Adenocarcinoma Large intestine
CTB-35F21.1/PSD2
t(5;5)(q31;q31)

Pintarelli et al 2016, Oncotarget
  Nonneoplastic epithelial disorder/lesion Lung
HARS2/ZMAT2
t(5;5)(q31;q31)

Ren et al 2012, Cell Res
  Adenocarcinoma Prostate
RAD50/PDLIM4
t(5;5)(q31;q31)

Robinson et al 2017, Nature
  Adenocarcinoma Ovary
CTNNA1/KDM3B
t(5;5)(q31;q31)
  Adenocarcinoma Breast
CTNNA1/KDM3B
t(5;5)(q31;q31)

Rudin et al 2012, Nat Genet
  Undifferentiated carcinoma, small cell Lung
SKP1/CDKL3
t(5;5)(q31;q31)

Wen et al 2012, PLoS One
  Acute myeloid leukemia, NOS
HARS2/ZMAT2
t(5;5)(q31;q31)

Yoshihara et al 2015, Oncogene
  Adenocarcinoma Ovary
UBE2D2/PAIP2
t(5;5)(q31;q31)
  Adenocarcinoma Prostate
FAM13B/CDC25C
t(5;5)(q31;q31)
  Adenocarcinoma Prostate
MATR3/KDM3B
t(5;5)(q31;q31)
  Adenocarcinoma Lung
SPOCK1/ARHGAP26
t(5;5)(q31;q31)
  Adenocarcinoma Kidney
PAIP2/CDC25C
t(5;5)(q31;q31)
  Squamous cell carcinoma Oral cavity
PITX1/P4HA2
t(5;5)(q31;q31)
  Astrocytoma, grade III-IV/Glioblastoma Brain
NR3C1/HMHB1
t(5;5)(q31;q31)
  Adenocarcinoma Breast
HARS/FAM53C
t(5;5)(q31;q31)
  Adenocarcinoma Breast
MATR3/PCDHA2
t(5;5)(q31;q31)
  Adenocarcinoma Breast
AFF4/FSTL4
t(5;5)(q31;q31)
  Adenocarcinoma Breast
PCDHA11/ANKHD1
t(5;5)(q31;q31)
  Adenocarcinoma Breast
NRG2/CYSTM1
t(5;5)(q31;q31)
  Adenocarcinoma Breast
SIL1/NRG2
t(5;5)(q31;q31)
  Adenocarcinoma Breast
ANKHD1/CYSTM1
t(5;5)(q31;q31)
  Adenocarcinoma Breast
PPP2CA/CDKL3
t(5;5)(q31;q31)
  Adenocarcinoma Breast
VDAC1/SKP1
t(5;5)(q31;q31)
  Adenocarcinoma Breast
MATR3/CTNNA1
t(5;5)(q31;q31)